3/4
11:53 am
rlyb
Rallybio Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Rallybio Corporation - RLYB
Medium
Report
Rallybio Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Rallybio Corporation - RLYB
3/3
07:34 am
rlyb
Rallybio to acquire Candid Therapeutics [Yahoo! Finance]
Medium
Report
Rallybio to acquire Candid Therapeutics [Yahoo! Finance]
3/2
04:22 pm
rlyb
Rallybio Corporation (RLYB) M&A Call Prepared Remarks Transcript [Seeking Alpha]
Low
Report
Rallybio Corporation (RLYB) M&A Call Prepared Remarks Transcript [Seeking Alpha]
2/17
08:00 am
rlyb
Rallybio Announces Positive Data for RLYB116 Phase 1 Study Demonstrating Complete and Sustained Inhibition of Terminal Complement
High
Report
Rallybio Announces Positive Data for RLYB116 Phase 1 Study Demonstrating Complete and Sustained Inhibition of Terminal Complement
2/3
07:06 pm
rlyb
Rallybio Announces Reverse Stock Split of Common Stock [Yahoo! Finance]
Medium
Report
Rallybio Announces Reverse Stock Split of Common Stock [Yahoo! Finance]
2/3
04:05 pm
rlyb
Rallybio Announces Reverse Stock Split of Common Stock
Medium
Report
Rallybio Announces Reverse Stock Split of Common Stock
12/30
04:14 pm
rlyb
Rallybio (NASDAQ:RLYB) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Rallybio (NASDAQ:RLYB) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.